Key facts
- This page summarizes Robin Kramer's Form 4 filing for BIOGEN INC. (BIIB).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 17 Feb 2026, 20:14.
Robin Kramer - 13 Feb 2026 Form 4 Insider Report for BIOGEN INC. (BIIB)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- BIIB
- Reported as of
- 13 Feb 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 17 Feb 2026, 20:14:49 UTC
- Prior SEC filing
- 10 Feb 2026
- Next SEC filing
- 11 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Wendell Taylor, attorney-in-fact for Robin Kramer
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robin Kramer filed Form 4 for BIOGEN INC. (BIIB) on 17 Feb 2026.
Change
- Previous filing in this sequence was filed on 10 Feb 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001609222
Primary reporting owner
Kramer Robin
- Relationship
- Chief Financial Officer
- Address
- 225 BINNEY STREET, CAMBRIDGE
- Signature
- /s/ Wendell Taylor, attorney-in-fact for Robin Kramer
- Signature date
- 17 Feb 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BIIB
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- $0
- Shares
- +8,450
- Change %
- Price
- $0.000000
- Shares after
- 8,450
- Date
- 13 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,450
- Exercise price
- $0.000000
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026.